9 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
New Vertebral, Clinical ... Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM
Chest radiography showed perihilar opacities in both lungs with free air in the mediastinum (Panel A,
#Clinical #PCC # ... IM #EM #Pneumomediastinum ... #Influenza #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
point of major or clinically ... warfarin (Panel A) #EBM ... #Cardiology #IM ... #REDUAL #Dabigatran ... AtrialFibrillation #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
are in routine clinical ... been tested in clinical ... been shown to reduce ... Pathophysiology #IM ... Immunosuppression #NEJM
The pulmonary embolism rule-out criteria (PERC) was created to reduce testing in patients who have a
was created to reduce ... prospective randomized clinical ... #Diagnosis #EM # ... IM #PERC #Rule # ... PulmonaryEmbolism #RebelEM
Evolution of Purpura Fulminans - On physical examination, he had small purpura on his legs (Panel
#Clinical #Derm ... #EM #IM #PurpuraFulminans ... Meningococcemia #NEJM